Follow the people · Insider
Christopher Horan
Christopher Horan files insider transactions with the SEC as a chief tech operations officer of Artiva Biotherapeutics (ARTV). We hold 2 disclosed purchases and sales filed since 9 May 2018, 1 of them in the last 90 days.
- Files forARTV
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure4 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 12 September 2024 — 3 September 2026Chief Tech Operations Officer · Artiva Biotherapeutics (ARTV)15 Form 4 lines · source: SEC Form 4
- Filed 7 May 2018 — 20 February 2020Chief Technical Ops Officer · Dermira (DERM)12 Form 4 lines · source: SEC Form 4
Everything they disclosed
27 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 10,366 shares of Artiva BiotherapeuticsSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 7,002 shares of Artiva BiotherapeuticsSEC Form 419 May 2026Common Stock · traded 19 May 2026 · filed 19 May 2026
- was granted 117,300 shares of Artiva BiotherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- had shares withheld for tax on 2,187 shares of Artiva BiotherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- was granted 117,300 shares of Artiva BiotherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- had shares withheld for tax on 2,187 shares of Artiva BiotherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- returned to the issuer 77,519 shares of Artiva Biotherapeutics (a derivative holding)SEC Form 412 December 2025Employee Stock Option (Right to Buy) · traded 12 December 2025 · filed 12 December 2025
- returned to the issuer 9,119 shares of Artiva Biotherapeutics (a derivative holding)SEC Form 412 December 2025Employee Stock Option (Right to Buy) · traded 12 December 2025 · filed 12 December 2025
- returned to the issuer 20,519 shares of Artiva Biotherapeutics (a derivative holding)SEC Form 412 December 2025Employee Stock Option (Right to Buy) · traded 12 December 2025 · filed 12 December 2025
- was granted 107,156 shares of Artiva BiotherapeuticsSEC Form 412 December 2025Common Stock · traded 12 December 2025 · filed 12 December 2025
- had shares withheld for tax on 1,899 shares of Artiva BiotherapeuticsSEC Form 417 November 2025Common Stock · traded 15 November 2025 · filed 17 November 2025
- had shares withheld for tax on 1,341 shares of Artiva BiotherapeuticsSEC Form 418 August 2025Common Stock · traded 15 May 2025 · filed 18 August 2025
- had shares withheld for tax on 3,577 shares of Artiva BiotherapeuticsSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- was granted 60,000 shares of Artiva BiotherapeuticsSEC Form 428 February 2025Common Stock · traded 26 February 2025 · filed 28 February 2025
- was granted 25,000 shares of Artiva BiotherapeuticsSEC Form 413 September 2024Common Stock · traded 12 September 2024 · filed 13 September 2024
- returned to the issuer 140,000 shares of Dermira (a derivative holding)SEC Form 424 February 2020Director Stock Option (right to buy) · traded 20 February 2020 · filed 24 February 2020
- returned to the issuer 65,000 shares of Dermira (a derivative holding)SEC Form 424 February 2020Director Stock Option (right to buy) · traded 20 February 2020 · filed 24 February 2020
- returned to the issuer 53,333 shares of Dermira (a derivative holding)SEC Form 424 February 2020Restricted Stock Unit · traded 20 February 2020 · filed 24 February 2020
- returned to the issuer 15,000 shares of Dermira (a derivative holding)SEC Form 424 February 2020Restricted Stock Unit · traded 20 February 2020 · filed 24 February 2020
- returned to the issuer 21,400 shares of DermiraSEC Form 424 February 2020Common Stock · traded 20 February 2020 · filed 24 February 2020
- exercised options over 26,667 shares of Dermira (a derivative holding)SEC Form 421 May 2019Restricted Stock Unit · traded 17 May 2019 · filed 21 May 2019
- exercised options over 26,667 shares of DermiraSEC Form 421 May 2019Common Stock · traded 17 May 2019 · filed 21 May 2019
- had shares withheld for tax on 9,222 shares of DermiraSEC Form 421 May 2019Common Stock · traded 17 May 2019 · filed 21 May 2019
- was granted 65,000 shares of Dermira (a derivative holding)SEC Form 414 February 2019Employee Stock Options (Right to buy) · traded 12 February 2019 · filed 14 February 2019
- was granted 15,000 shares of Dermira (a derivative holding)SEC Form 414 February 2019Restricted Stock Unit · traded 12 February 2019 · filed 14 February 2019
- was granted 140,000 shares of Dermira (a derivative holding)SEC Form 49 May 2018Stock Options (Right to buy) · traded 7 May 2018 · filed 9 May 2018
- was granted 80,000 shares of Dermira (a derivative holding)SEC Form 49 May 2018Restricted Stock Unit · traded 7 May 2018 · filed 9 May 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.